myEndometrialCancerTeam

Your care team's approach to monitoring with multiple screening methods is thorough. While your Signatera readings show a slight increase, they remain below the analytical range, which explains why your consultant believes a CT scan may not show anything at these levels.

Regarding tumor markers, CA-125 (not CA-127) is the Show Full Answer

Your care team's approach to monitoring with multiple screening methods is thorough. While your Signatera readings show a slight increase, they remain below the analytical range, which explains why your consultant believes a CT scan may not show anything at these levels.

Regarding tumor markers, CA-125 (not CA-127) is the blood test typically used for endometrial cancer monitoring. This test can help indicate if cancer has spread outside the uterus, though it's not used for initial diagnosis. It's worth noting that some symptoms you mentioned, like UTI, can be related to brachytherapy side effects. Common side effects can include:
- Pain while urinating
- Blood in urine
- Vaginal irritation
- Bladder irritation (radiation cystitis)

Continue to communicate any new or changing symptoms with your care team, as they can help manage these side effects while monitoring your condition.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

3 New Treatments for Endometrial Cancer and What To Ask Your Doctor

6 Tests To Diagnose Endometrial Cancer